Clinical Trials Logo

Clinical Trial Summary

1. The accuracy of the sensors (Flash vs Enlite glucose monitoring) will be evaluated with a standardized breakfast test. Patients receive a standardized breakfast. The usual insulin bolus will be administered at breakfast. After breakfast, a venous blood sample is taken for 2 hours every 15 minutes to determine the blood sugar. At the same time, the glucose value shown by the sensors will be noted. A comparison of the blood glucose value with the data recorded by the sensor can evaluate the accuracy of the sensor and also estimate the lag-time between the sensor glucose and the venous glucose.

2. Patient satisfaction will be evaluated using a questionnaire that will be completed after the Enlite sensor has been worn for 1 month.

3. The development of skin reactions will be checked by a short questionnaire, supplemented with a picture of possible skin phenomena.

4. The data recorded by the FreeStyle sensor (average glucose,% above target,% within target,% under target, amount of hypoglycemia) in the month prior to sensor switching will be compared to the same data recorded by the Enlite sensor during the first month of use.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT03249974
Study type Observational
Source Jessa Hospital
Contact
Status Completed
Phase
Start date July 5, 2017
Completion date July 4, 2018

See also
  Status Clinical Trial Phase
Completed NCT03623113 - The Dietary Education Trial in Carbohydrate Counting (DIET-CARB Study in Type 1 Diabetes N/A
Withdrawn NCT03396484 - Methyldopa for Reduction of DQ8 Antigen Presentation in At-Risk Subjects for Type 1 Diabetes Phase 2
Completed NCT03117998 - Multiple Dose Study to Evaluate the Efficacy, Safety and Pharmacodynamics of REMD-477 in Subjects With Type 1 Diabetes Mellitus Phase 2
Recruiting NCT03369821 - EXtremely Early-onset Type 1 Diabetes EXtremely Early-onset Type 1 Diabetes (A Musketeers' Memorandum Study)
Completed NCT03202732 - DiabetesFlex - Patient Involvement and Patient-reported Outcome Measures in Type 1 Diabetes N/A
Completed NCT03704818 - Dapagliflozin Effects on Hypoglycemia Phase 1
Recruiting NCT03864991 - Lifestyle Changes and Glycemic Control in T1D N/A
Completed NCT03725657 - Correlation Between Exercise and Insulin Dose in a Camp for Pediatric Type 1 Patients
Completed NCT02985866 - The International Diabetes Closed Loop (iDCL) Trial: Protocol 1 N/A
Completed NCT03003806 - Evaluation of the Dreamed Advisor Pro for Automated Insulin Pump Setting Adjustments in Children and Adolescents With Type 1 Diabetes- The Advice4U Pro Study N/A
Withdrawn NCT04147637 - FreeStyle Libre Plus Bluetooth Transmitter Adjunct: Can This Improve Glucose Accuracy and Reduce Burden of Hypoglycaemia N/A
Completed NCT03970889 - Real-time Reminders To Decrease Late or Missed Meal Boluses N/A
Recruiting NCT04589325 - Ixekizumab Diabetes Intervention Trial (I-DIT) Phase 2
Completed NCT03367390 - A Study of an Automated Insulin Delivery System in Participants With Type 1 Diabetes Mellitus (T1DM) Phase 1
Completed NCT03738852 - Mechanisms for Restoration of Hypoglycemia Awareness Early Phase 1
Completed NCT03406585 - Wharton´s Jelly Derived Mesenchymal Stromal Cell Treatment of Adult Patients Diagnosed With Type I Diabetes Phase 1/Phase 2
Completed NCT03859856 - Ovarian Reserve in Diabetes Mellitus
Withdrawn NCT04102202 - BOL-DP-o-05 as an Add-On Treatment of Subjects With Newly Diagnosed Type 1 Diabetes Mellitus Phase 1/Phase 2
Terminated NCT03353792 - Using an Artificial Pancreas System in Older Adult Type 1 Diabetes Mellitus Patients N/A
Recruiting NCT03811470 - China Diabetes Registry by Metabolic Management Center